ECMO in Acute Myocardial Infarction | Apex Hospitals Jaipur
ECMO in Acute Myocardial Infarction: When the Heart Needs a Lifeline
Understanding how Extracorporeal Membrane Oxygenation rescues patients from cardiogenic shock after a severe heart attack — and what makes rapid, expert deployment critical.
By the Clinical Team at Apex Hospitals · Published July 2025
A massive heart attack — medically termed acute myocardial infarction (AMI) — can strike without warning and overwhelm the heart's ability to pump blood within minutes. When the resulting circulatory collapse, known as cardiogenic shock, fails to respond to standard resuscitation, clinicians face a narrow window in which to act. Extracorporeal Membrane Oxygenation, or ECMO, has emerged as one of the most powerful tools available in that window — a temporary mechanical circulatory support system that effectively takes over the work of the heart and lungs while the underlying cause is treated.
This article explains what ECMO is, why it is increasingly used in AMI-related cardiogenic shock, how the procedure works in an emergency setting, and what patients and families in Jaipur and across Rajasthan should know about accessing this life-saving technology.
What Is Cardiogenic Shock After a Heart Attack?
During an acute myocardial infarction, a coronary artery becomes blocked, cutting off blood supply to a section of heart muscle. If the blockage is large or treatment is delayed, the damaged muscle can no longer contract effectively. Cardiac output drops sharply, blood pressure falls, and vital organs — kidneys, brain, liver — begin to suffer from oxygen deprivation. This cascade is cardiogenic shock.
According to data published by the American Heart Association, cardiogenic shock complicates approximately 5–10% of all ST-elevation myocardial infarctions (STEMIs) and carries an in-hospital mortality rate that has historically exceeded 40–50%, even with early revascularisation. Vasopressors and inotropes can temporarily raise blood pressure, but they also increase the heart's oxygen demand — the last thing an already-injured myocardium needs. This is precisely the gap that mechanical circulatory support, and specifically ECMO, is designed to fill.
Patients with complex cardiac conditions in Rajasthan now have access to this technology closer to home than ever before.
How ECMO Works: The Basics
ECMO is a form of extracorporeal life support (ECLS). Blood is drawn from the patient's body through a large cannula, passed through an oxygenator membrane that adds oxygen and removes carbon dioxide, and then returned to the circulation — either to a vein (Veno-Venous, or VV-ECMO, primarily for lung failure) or to an artery (Veno-Arterial, or VA-ECMO, for combined heart and lung failure).
In the context of acute myocardial infarction and cardiogenic shock, VA-ECMO is the configuration of choice. It bypasses both the heart and the lungs, delivering oxygenated blood directly into the arterial system. This achieves two critical goals simultaneously:
Haemodynamic stabilisation: Adequate blood pressure and organ perfusion are restored without relying on the failing heart.
Myocardial rest: By reducing the preload and afterload demands on the heart, ECMO allows the injured muscle time to recover — or buys time for a definitive intervention such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
The ECMO programme at Apex Hospitals operates both VV and VA configurations, supported by a dedicated critical care team trained in rapid cannulation and circuit management.
ECMO as a Bridge: Four Key Clinical Scenarios
In AMI-related cardiogenic shock, ECMO is rarely the final treatment — it is a bridge. Clinicians describe four distinct bridging strategies:
1. Bridge to Revascularisation
The most common scenario. ECMO stabilises the patient long enough for the interventional cardiology team to open the blocked coronary artery via primary PCI or emergency bypass surgery. Once blood flow is restored to the myocardium, the heart often recovers sufficient function to be weaned off ECMO within days.
2. Bridge to Recovery
In some patients — particularly those with myocarditis or stress cardiomyopathy mimicking AMI — the heart muscle is stunned rather than permanently damaged. ECMO support for 5–14 days can allow spontaneous myocardial recovery, after which the device is removed.
3. Bridge to a Durable Device
When the heart cannot recover and the patient is a candidate for a long-term ventricular assist device (VAD), ECMO provides short-term support while the patient is evaluated and prepared for implantation.
4. Bridge to Transplant Decision
In carefully selected patients with refractory cardiogenic shock, ECMO can maintain organ function while the multidisciplinary team assesses transplant candidacy and listing status.
The ECMO Emergency Response: Speed Is Everything
Unlike elective procedures, ECMO in AMI is almost always initiated under emergency conditions. The sequence typically unfolds as follows:
Recognition: The emergency or cardiology team identifies refractory cardiogenic shock — persistent hypotension, rising lactate, and end-organ dysfunction despite vasopressors and initial resuscitation.
Rapid cannulation: Under ultrasound guidance, large-bore cannulae are placed — typically in the femoral vein and femoral artery — often within 30–60 minutes of the decision to proceed.
Circuit initiation: The ECMO pump is started, and flow is titrated to achieve a target cardiac index and mean arterial pressure.
Concurrent revascularisation: The interventional cardiology team proceeds to the catheterisation laboratory for primary PCI while the patient is on ECMO support.
ICU management: The patient is transferred to the Cardiac ICU for continuous monitoring, anticoagulation management, and daily assessment of cardiac recovery.
Weaning: As cardiac function improves, ECMO flow is gradually reduced. Echocardiography guides the decision to decannulate.
This entire pathway demands a seamlessly coordinated team: emergency physicians, interventional cardiologists, cardiac intensivists, perfusionists, and specialised nursing staff — all available around the clock. The ICU and critical care team at Apex Hospitals is structured precisely for this level of integrated emergency response.
What the Evidence Says About ECMO in AMI-Cardiogenic Shock
The clinical evidence for ECMO in AMI-related cardiogenic shock has evolved significantly over the past decade. Early observational data showed promising survival signals, and ECMO became widely adopted in high-volume centres before randomised trial data were available.
The landmark ECMO-CS trial and subsequent registry analyses have added nuance: ECMO's benefit is most pronounced when initiated early, in appropriately selected patients, at centres with high procedural volume and robust post-ECMO ICU protocols. Patient selection — accounting for age, comorbidities, neurological status, and the reversibility of the underlying cause — is now recognised as the single most important determinant of outcome.
A growing body of PubMed-indexed literature supports the use of multidisciplinary Shock Teams — structured groups that convene rapidly to make real-time decisions about escalating mechanical circulatory support — as a key organisational strategy to improve ECMO outcomes in AMI.
At Apex Hospitals, the ECMO programme has achieved an 80% survival rate in ECMO cases — one of the strongest reported outcomes in Rajasthan — reflecting both careful patient selection and the depth of the supporting critical care infrastructure.
Risks, Complications, and How They Are Managed
ECMO is a high-complexity intervention and carries real risks. Patients and families deserve a clear, honest understanding of these:
Limb ischaemia: The femoral arterial cannula can reduce blood flow to the leg. A distal perfusion cannula is routinely placed to mitigate this risk, and limb perfusion is monitored continuously.
Bleeding: Systemic anticoagulation required to prevent clot formation in the circuit increases bleeding risk, particularly at cannulation sites and in the gastrointestinal tract.
Thromboembolism: Clots can form within the circuit and embolise. Regular circuit checks and anticoagulation monitoring are essential.
Infection: Prolonged ECMO support increases the risk of bloodstream infections. Strict aseptic protocols and early antibiotic stewardship are critical.
Left ventricular distension: VA-ECMO increases afterload on the left ventricle. In some patients, additional unloading strategies — such as an intra-aortic balloon pump — are used concurrently.
The cardiothoracic surgery team works alongside the cardiac intensivists at Apex Hospitals to manage these complications proactively, with daily multidisciplinary ward rounds and real-time haemodynamic monitoring in the Cardiac ICU.
Who Is — and Is Not — a Candidate for ECMO in AMI?
Not every patient in cardiogenic shock will benefit from ECMO. Appropriate candidacy assessment is a clinical and ethical responsibility. Factors that generally favour ECMO initiation include:
Refractory cardiogenic shock despite optimal medical therapy
A potentially reversible cause (acute coronary occlusion amenable to PCI, fulminant myocarditis)
Preserved neurological function or uncertain neurological status in the acute phase
Absence of severe, irreversible comorbidities that would preclude meaningful recovery
Availability of a clear bridging strategy (revascularisation, VAD, or transplant evaluation)
Conversely, patients with prolonged cardiac arrest without return of spontaneous circulation, severe peripheral vascular disease precluding cannulation, or advanced multi-organ failure with no reversible cause are generally not suitable candidates. These decisions require experienced clinical judgment and, ideally, a structured Shock Team discussion.
ECMO and the Broader Cardiac Care Pathway at Apex Hospitals, Jaipur
ECMO does not exist in isolation — its outcomes depend entirely on the quality of the surrounding cardiac care ecosystem. At Apex Hospitals' Malviya Nagar campus in Jaipur, the ECMO programme is embedded within a comprehensive cardiac infrastructure that includes:
A Hybrid Cath Lab enabling primary PCI and complex endovascular procedures around the clock
A dedicated Cardiac ICU with continuous haemodynamic monitoring and specialist intensivist cover
Both VV and VA ECMO machines with trained perfusionists available 24×7
Emergency operating theatres available at all hours for surgical revascularisation when needed
The HOPE Tele-ICU Command Centre, connecting 18 partner sites across Rajasthan so that critically ill patients in remote districts can be stabilised and transferred with expert guidance before they arrive
This integrated model — from the moment a patient collapses in a district hospital to the moment they are weaned off ECMO in Jaipur — is what distinguishes a true ECMO centre from a facility that merely owns the equipment. The HOPE programme, featured in the Harvard Business Review and recognised at the GovConnect Conclave for HealthTech Excellence, has already reduced patient cost burden by ₹40,000–₹50,000 per day for families who would otherwise have needed to travel to metropolitan centres outside Rajasthan.
Patients requiring post-ECMO rehabilitation and cardiac recovery are supported by the physiotherapy and rehabilitation team at Apex, ensuring a structured return to function after discharge from the ICU.
What Families Should Know: Practical Guidance
If a loved one is in cardiogenic shock after a heart attack, the most important thing a family can do is ensure rapid transfer to a centre with ECMO capability. Time from shock onset to ECMO initiation is a major determinant of outcome — every hour of delay allows further end-organ damage to accumulate.
Once ECMO is initiated, families should expect:
Daily updates from the treating intensivist and cardiologist
A clear explanation of the bridging strategy and expected timeline
Honest communication about prognosis, including the possibility that the heart may not recover sufficiently
Support from the hospital's social work and counselling team during what is an intensely stressful period
Apex Hospitals is empanelled under Ayushman Bharat and major insurance and TPA schemes, which can significantly reduce the financial burden of ECMO-supported care for eligible patients. The internal medicine and general care teams coordinate with insurance desks to facilitate pre-authorisation as quickly as possible in emergency situations.
Frequently Asked Questions
How long can a patient stay on ECMO after a heart attack?
Most patients with AMI-related cardiogenic shock are supported on VA-ECMO for 3–10 days. If the heart recovers after successful revascularisation, weaning can begin earlier. Prolonged runs beyond 2–3 weeks are associated with higher complication rates and require careful reassessment of the bridging strategy.
Is ECMO the same as a heart-lung bypass machine used in open-heart surgery?
They share the same basic principle — oxygenating blood outside the body — but differ in important ways. Cardiopulmonary bypass (CPB) used in the operating theatre is a short-term, high-flow system designed for hours of use during surgery. ECMO is designed for days to weeks of support in the ICU, uses smaller cannulae placed percutaneously, and allows the patient to remain conscious and, in some cases, mobile.
Can ECMO be initiated outside the hospital — for example, during transport?
Mobile ECMO — initiating the circuit at a referring hospital and transporting the patient on support — is practised at a small number of highly specialised centres globally. At present, the standard pathway at Apex Hospitals involves stabilising the patient at the referring site with vasopressors and arranging the fastest possible transfer, with ECMO initiated on arrival in Jaipur. The HOPE Tele-ICU network facilitates real-time guidance to referring teams during this critical transfer window.
What happens if the heart does not recover on ECMO?
If serial echocardiography shows no meaningful recovery of cardiac function after an adequate trial of ECMO support, the multidisciplinary team will discuss the options: escalation to a durable ventricular assist device, evaluation for cardiac transplantation, or, in cases where no further options are appropriate, a compassionate withdrawal of support. These conversations are conducted with full transparency and with the family's values and wishes at the centre.
Is ECMO covered under Ayushman Bharat or private insurance?
ECMO-related procedures and ICU care are covered under several government schemes and private insurance policies, though coverage limits and pre-authorisation requirements vary. Apex Hospitals' insurance coordination team works proactively to obtain approvals as quickly as possible in emergency situations. Families are encouraged to share insurance details at the time of admission.
A Note on Prevention: Reducing the Risk of a Severe Heart Attack
The best outcome in AMI-related cardiogenic shock is the one that never has to happen. Cardiovascular risk reduction — managing hypertension, diabetes, dyslipidaemia, and smoking — remains the most effective strategy. Regular cardiac check-ups, early recognition of warning symptoms (chest pain, breathlessness, sweating, jaw or arm pain), and calling emergency services without delay are the steps that most often determine whether a patient reaches the hospital in time for standard treatment — or arrives in shock requiring ECMO.
If you or a family member has known cardiac risk factors, a consultation with the cardiology specialists at Apex Hospitals, Jaipur can help establish a personalised prevention and monitoring plan. The diabetes and endocrine sciences department works closely with the cardiac team to manage metabolic risk factors that significantly increase AMI risk.
References
Have Questions About ECMO or Cardiac Emergency Care?
Our cardiac and critical care specialists at Apex Hospitals, Malviya Nagar, Jaipur are available to speak with you or your family — whether you need urgent guidance or want to understand your options in advance.